Moore Capital Management, LP Natera, Inc. Transaction History

Moore Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $1.21 Million - $1.93 Million	-33,100 Reduced 44.13%	41,900 $2.33 Million
Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $2.56 Million - $3.59 Million	75,000 New	75,000 $3.01 Million
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $416,414 - $1.25 Million	-13,734 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $121,281 - $167,314	1,406 Added 11.4%	13,734 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$100.17 - $126.36 $1.23 Million - $1.56 Million	12,328 New	12,328 $1.37 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $14.3 Million - $19.8 Million	-165,618 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $5.98 Million - $8.13 Million	-65,377 Reduced 28.3%	165,618 $16.8 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $9.92 Million - $16.6 Million	148,744 Added 180.84%	230,995 $23 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $3.77 Million - $5.98 Million	82,251 New	82,251 $5.94 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.